Difficult-to-treat IBD is prevalent among approximately a quarter of individuals with IBD in a tertiary care setting.

Fostemsavir plus optimized background therapy was associated with improvements in immune biomarkers among HTE patients with MDR HIV infection.

The mRNA-1273 COVID-19 booster dose was safe and elicited robust immune responses among children aged 6 months to 5 years and 6 to 11 years.

Neuropathy and retinopathy are positively associated with moderate/severe periodontitis, according to a study published online.

Among cancer survivors, excess body weight is associated with an increased risk for a second primary malignant neoplasm.

Reduced AMR proportions were noted for multiple pathogens from 2007 to 2019, but some previously declining trends have reversed course since the COVID-19 pandemic.

The mortality rate in IBD, ranging from 1999 to 2020, remained stable until 2018 when rates began to increase until 2020.

The aTIV vaccine provides better protection against influenza-related medical encounters than the HD-TIV vaccine in high-risk older adults.

Those who receive the COVID-19 vaccine during pregnancy are less likely to be hospitalized for COVID-19; however, vaccine uptake in this population is suboptimal.

SGLT-2 inhibitor use vs DPP-4 inhibitor use was associated with a lower risk for incidental Parkinson disease among older adults with type 2 diabetes.

Long COVID is common among veterans in the Airborne Hazards and Open Burn Pit Registry; however, the risk is not augmented by deployment exposures.

For patients with type 2 diabetes, sodium-glucose cotransporter 2 inhibitor (SGLT2i) use is associated with reduced risks for incident dementia and Parkinson disease (PD).